Tauriga Sciences, Inc. and Cannabis Health Form “Foundational Partnership”
LOS ANGELES, May 13, 2015 /PRNewswire/ — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, announced today that it has formed a “Foundational Partnership” with Cannabis Health, an information based media company that focuses on the health and science of cannabis. Under this partnership agreement, Tauriga and its principals will provide Cannabis Health with medical and scientific content for Cannabis Health’s print and electronic publication and dissemination. Cannabis Health will help increase exposure to Tauriga and its natural wellness products. Both companies will help each other market their shared vision of utilizing cannabis as a natural medicine.
Tauriga’s natural wellness product line currently consists of six products. Two of these products utilize cannabidiol (CBD) oil extracted from non-GMO industrial hemp as its key ingredient: CannaCaviar, a premium line of CBD soft gels, and TopiCanna, a proprietary topical medicinal cannabis cream. Many who have used topical cannabis creams have reported decreased musculoskeletal pain. Both TopiCanna and CannaCaviar are designed to provide potential natural wellness and healing properties without psychoactive effects. In addition to CannaCaviar and TopiCanna, Tauriga has four non-cannabis containing natural wellness dietary supplements: IndiCalm, natural calming formula that does not induce cognitive impairment; ClearNaze, a natural decongestant without stimulant or drowsiness effects; Satietiva, an amino acid-based appetite suppressant; and MendCan, a highly pure, potent and palatable Omega 3 supplement Product information, labels and testimonials are available on Tauriga’s e-commerce website, www.taurigastore.com.
Originally founded in 2002, Cannabis Health has online web platform and publishing model, a printed publication, and one of the longest standing brands in the industry.
Cannabis Health Co-Founder Dean Sutton comments, “We are very pleased to be aligned with a company such as Tauriga Sciences — a company that has health, science and research as the foremost priority in the formulation and delivery of their natural health products to the marketplace. Led by an impressive team, we look forward to helping them take their knowledge, information and experience to the world through the Cannabis Health platform and publication.”
About Tauriga Sciences, Inc.:
Tauriga Sciences, Inc. (TAUG) is a diversified life sciences company focused on generating profitable revenues in the natural wellness sector and in developing a proprietary synthetic biology platform technology. The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company’s business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. Please visit the Company’s corporate website atwww.tauriga.com and the Company’s e-commerce website at www.taurigastore.com.
About Cannabis Health
Cannabis Health is an information based media company that focuses on the health and science of cannabis. Originally created in small town British Columbia, Canada in 2002, the team came together with one sound mission in mind – to deliver the best information on the health and science of cannabis to the world. This was before the utilization of the internet, digital publishing, social media, and being able to access extensive distribution and marketing channels. And most importantly, before the industry was the size that it is today.
Cannabis Health has expanded itself with a multiplied business model, increased access, distribution, partnerships, resources, and value to the market and population at large. Working closely with the industry, patients, physicians, leading companies, analysts, scientists, researchers and universities, the Cannabis Health web platform and printed publication will continue the legacy of one of the longest standing brands in the cannabis industry. For more information, please visit www.CannabisHealth.com.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. Any securities offered or issued in connection with the above-referenced merger and/or investment have not been registered, and will be offered pursuant to an exemption from registration.
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on TAUG’s predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which TAUG has little or no control. Such forward-looking statements are made only as of the date of this release, and TAUG assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by TAUG with the Securities and Exchange Commission. This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the “Securities Act”) or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.
Food and Drug Administration Disclaimer: None of the statements contained in this press release regarding any of the products either offered or to be offered in the future by the Company have been evaluated by the Food and Drug Administration. Additionally, none of the products is intended to diagnose, treat, cure, or prevent any disease.